trypan blue tb (Valiant Co Ltd)
Structured Review
Trypan Blue Tb, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/congo/Trypan+Blue/pmc03156357-132-8-12
Average 96 stars, based on 176 article reviews
Images
Related Articles
Cell Characterization:Article Title: Evaluating the regenerative capacity of biosynthesized nano formulated 3D scaffolds in scald burn healing Article Snippet: .. The cell pellet was suspended in 1 mL PBS and manual cell count was performed using a Neubauer chamber with the aid of 0.4% other:Article Title: Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Article Snippet: Article Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer Graphical abstract Highlights • Cyclic STAT3 decoy (CS3D) inhibits murine HNSCC tumors via CD8+ cells • CS3D is well tolerated in a clinical trial of pet cats with oral cancer • CS3D induces a 35% disease control rate in pet cats with oral cancer • Analysis of the clinical trial specimens identifies potential predictive biomarkers Authors Jennifer R. Grandis, Katherine A. Skorupski, Ning Cheng, ..., Adam B. Olshen, Ellen E. Sparger, Daniel E. Johnson Correspondence jennifer.grandis@ucsf.edu (J.R.G.), daniel.johnson@ucsf.edu (D.E.J.). In brief Grandis et al. evaluate the activity of a cyclic oligonucleotide inhibitor of STAT3, CS3D, in immunocompetent models of mouse head and neck cancer and in a clinical trial of pet cats with oral cancer.. CS3D has low toxicity and modulation of immune parameters is associated with anti-tumor activity. Article Title: Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy Article Snippet: The protein expression levels of CXCL2 in tumor cells CM and IL-12b in TANs CM were measured by using human enzyme-linked immunosorbent assay (ELISA) kit (Elabscience, Cat. #E-EL-H1904, Cat. #E-EL-H0151) according to the manufacturer’s instructions. Incubation:Article Title: Modeling effective doses of therapeutic antibodies targeting clustered surface receptors Article Snippet: .. After 72 hours incubation at 37°C in 5% CO2 incubator, the number of living cells was counted using Incubator:Article Title: Modeling effective doses of therapeutic antibodies targeting clustered surface receptors Article Snippet: .. After 72 hours incubation at 37°C in 5% CO2 incubator, the number of living cells was counted using Software:Article Title: Modeling effective doses of therapeutic antibodies targeting clustered surface receptors Article Snippet: .. After 72 hours incubation at 37°C in 5% CO2 incubator, the number of living cells was counted using Staining:Article Title: Methods and compositions for targeting cancer cells in metastases Article Snippet: .. Following treatment with either HK-BLMP6 (0.1 mM) or HK-BLMP5 (0.3 mM) in 0.5 ml serum free culture media for 8 hours, cells were stained with 0.4% Article Title: Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy. Article Snippet: .. The purity and cell viability of neutrophils were assessed by |
